Human papillomavirus as an independent risk factor of invasive cervical and endometrial carcinomas in Jordan

被引:19
|
作者
Abu-Lubad, Mohammad A. [1 ]
Jarajreh, Dua'a A. [1 ]
Helaly, Ghada F. [1 ,2 ]
Alzoubi, Hamed M. [1 ]
Haddadin, Weliam J. [3 ]
Dabobash, Mahmoud D. [4 ]
Albataineh, Eman M. [1 ]
Aqel, Amin A. [1 ]
Alnawaiseh, Nedal A. [5 ]
机构
[1] Mutah Univ, Fac Med, Med Microbiol & Immunol Dept, Al Karak, Jordan
[2] Alexandria Univ, Med Res Inst, Microbiol Dept, Alexandria, Egypt
[3] Royal Med Serv, Pathol Dept, Amman, Jordan
[4] Al Bashir Hosp, Pathol Dept, Amman, Jordan
[5] Mutah Univ, Fac Med, Community Med & Publ Hlth Dept, Al Karak, Jordan
关键词
Human papillomavirus; Invasive cervical carcinoma; Endometrial carcinoma; Chlamydia trachomatis; CHLAMYDIA-TRACHOMATIS; INTRAEPITHELIAL NEOPLASIA; IN-SITU; CANCER; WOMEN; PREVALENCE; HPV; INFECTION; GENOTYPES; LESIONS;
D O I
10.1016/j.jiph.2019.08.017
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Endometrial and cervical carcinomas are the most common gynecologic malignancies in Western world and many countries. The human papillomavirus (HPV) high-risk genotypes are associated with cervical carcinoma (CC). Chlamydia trachomatis (C. trachomatis), the most common sexually transmitted bacterial infection worldwide, considered a cofactor for HPV infection and CC. Information on HPV infection rate and type distribution among Jordanian women having CC is currently limited and unavailable among those with endometrial carcinoma. Therefore, the present study aimed to provide an updated estimate on HPV infection rate and its high-risk genotypes' distribution among Jordanian women by comparing data from invasive cervical carcinoma (ICC) to normal cervical tissues. Similarly, assessment of HPV infection rate was extended to the endometrial tissues. C. trachomatis infection was investigated as well to explore its possibility as HPV cofactor for induction of such carcinomas. Methods: Total DNA was extracted from 144 formaldehyde-fixed paraffin-embedded cervical and endometrial tissue, equally divided between age-matched control and carcinoma cases. Polymera se chain reaction (PCR) was used for general detection of HPV-DNA, high risk HPV-16 and 18 genotypes and C. trachomatis DNA using specific primers. Results: HPV infection was detected in 91.7% and 61.1% of cervical cancer patients and controls, respectively. Likewise, it was higher among cases (47.2%) than controls (13.8%) in endometrial biopsies. Significantly higher HPV infection rates were found among ICC and endometrial control biopsies of women >50 years. Out of 33 HPV positive ICC cases, single HPV-16 infections were detected in 69.7% compared to HPV-18 (15.2%), while HPV-16/18 co-infections were only found in three (9%) samples. C. trachomatis was not detected in all studied groups. Conclusion: The present study has successfully provided an updated estimate on HPV infection rate among Jordanian women with and without ICC and endometrial carcinoma. In addition, a lack of co -infection was observed between HPV and C. trachomatis in both cancer types. (C) 2019 The Authors. Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences.
引用
收藏
页码:613 / 618
页数:6
相关论文
共 50 条
  • [31] Human papillomavirus vaccination and cervical cancer risk
    Rahangdale, Lisa
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 383
  • [32] Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer
    Combes, Jean-Damien
    Pawlita, Michael
    Waterboer, Tim
    Hammouda, Doudja
    Rajkumar, Thangarajan
    Vanhems, Philippe
    Snijders, Peter
    Herrero, Rolando
    Franceschi, Silvia
    Clifford, Gary
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (10) : 2453 - 2461
  • [33] ANTIBODIES TO HUMAN PAPILLOMAVIRUS AND TO OTHER GENITAL INFECTIOUS AGENTS AND INVASIVE CERVICAL-CANCER RISK
    JHA, PKS
    BERAL, V
    PETO, J
    HACK, S
    HERMON, C
    DEACON, J
    MANT, D
    CHILVERS, C
    VESSEY, MP
    PIKE, MC
    MULLER, M
    GISSMANN, L
    LANCET, 1993, 341 (8853): : 1116 - 1118
  • [34] A cornucopia of screening and diagnostic techniques for human papillomavirus associated cervical carcinomas
    Ramzan, Memoona
    ul Ain, Noor
    Ilyas, Sadaf
    Umer, Muhammad
    Bano, Sadia
    Sarwar, Samreen
    Shahzad, Naveed
    Shakoori, Abdul Rauf
    JOURNAL OF VIROLOGICAL METHODS, 2015, 222 : 192 - 201
  • [35] Human papillomavirus DNA in invasive cervical carcinomas and its association with patient survival: A nested case-control study
    Franco, E
    Bergeron, J
    Villa, L
    Arella, M
    Richardson, L
    Arseneau, J
    Stanimir, G
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1996, 5 (04) : 271 - 275
  • [36] DETECTION OF HUMAN PAPILLOMAVIRUS DNA IN INVASIVE CARCINOMAS OF THE CERVIX BY INSITU HYBRIDIZATION
    OSTROW, RS
    MANIAS, DA
    CLARK, BA
    OKAGAKI, T
    TWIGGS, LB
    FARAS, AJ
    CANCER RESEARCH, 1987, 47 (02) : 649 - 653
  • [37] Independent prognostic role of human papillomavirus genotype in cervical cancer
    Dong Hang
    Meiqun Jia
    Hongxia Ma
    Jing Zhou
    Xiaoshuang Feng
    Zhangyan Lyu
    Jian Yin
    Hong Cui
    Yin Yin
    Guangfu Jin
    Zhibin Hu
    Hongbing Shen
    Kai Zhang
    Ni Li
    Min Dai
    BMC Infectious Diseases, 17
  • [38] Human papillomavirus prevalence in invasive cervical carcinoma by HIV Status
    Hugo De Vuyst
    Gathari Ndirangu
    Manivasan Moodley
    Vanessa Tenet
    Benson Estambale
    Chris JLM Meijer
    Peter JF Snijders
    Gary Clifford
    Silvia Franceschi
    Infectious Agents and Cancer, 7 (Suppl 1)
  • [39] Independent prognostic role of human papillomavirus genotype in cervical cancer
    Hang, Dong
    Jia, Meiqun
    Ma, Hongxia
    Zhou, Jing
    Feng, Xiaoshuang
    Lyu, Zhangyan
    Yin, Jian
    Cui, Hong
    Yin, Yin
    Jin, Guangfu
    Hu, Zhibin
    Shen, Hongbing
    Zhang, Kai
    Li, Ni
    Dai, Min
    BMC INFECTIOUS DISEASES, 2017, 17
  • [40] Human papillomavirus-independent cervical cancer: what are the implications?
    Schmeler, Kathleen M.
    Batman, Samantha H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (01) : 8 - 8